Effects of Statin Plus Ezetimibe on Coronary Plaques in Acute Coronary Syndrome Patients with Diabetes Mellitus: Sub-Analysis of PRECISE-IVUS Trial

Aim: Coronary plaque regression is weak in acute coronary syndrome (ACS) patients with diabetes mellitus (DM). We evaluated whether dual lipid-lowering therapy (DLLT) with ezetimibe and atorvastatin attenuates coronary plaques in ACS patients with DM. Methods: The prospective, randomized controlled,...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujisue, Koichiro, Yamanaga, Kenshi, Nagamatsu, Suguru, Shimomura, Hideki, Yamashita, Takuro, Nakao, Koichi, Nakamura, Sunao, Ishihara, Masaharu, Matsui, Kunihiko, Sakaino, Naritsugu, Miyazaki, Takashi, Yamamoto, Nobuyasu, Koide, Shunichi, Matsumura, Toshiyuki, Fujimoto, Kazuteru, Tsunoda, Ryusuke, Morikami, Yasuhiro, Matsuyama, Koushi, Oshima, Shuichi, Sakamoto, Kenji, Izumiya, Yasuhiro, Kaikita, Koichi, Hokimoto, Seiji, Ogawa, Hisao, Tsujita, Kenichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Atherosclerosis Society 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957031/
https://www.ncbi.nlm.nih.gov/pubmed/32435011
http://dx.doi.org/10.5551/jat.54726

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957031/
https://www.ncbi.nlm.nih.gov/pubmed/32435011
http://dx.doi.org/10.5551/jat.54726

Ejemplares similares